Plasma extracellular vesicle surface-located GAS6/PROS1 and CD39/CD73 attenuate inflammation.

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Extracellular vesicles (EVs) are implicated in intercellular communication.
• The role of plasma-derived EVs in regulating immune cell function remains incompletely understood.
• Understanding EV-mediated immune regulation is crucial for developing novel therapeutic strategies.

Purpose of the Study:

• To investigate the regulatory effects of plasma-derived EVs on macrophage and neutrophil activation.
• To elucidate the molecular mechanisms underlying EV-mediated immune modulation.
• To assess the impact of EVs on neutrophil-macrophage interactions.

Main Methods:

• Analysis of macrophage activation via MERTK-dependent signaling pathways.
• Assessment of neutrophil oxidative burst, degranulation, and cytokine secretion.
• Enzymatic assays for CD39 and CD73 activity on EVs.
• Investigation of adenosine receptor signaling (A2A) in neutrophils.
• Co-culture experiments to study neutrophil-macrophage interactions.

Main Results:

• Plasma EVs activate macrophages through GAS6/PROS1-dependent MERTK signaling.
• EVs modulate neutrophil functions, including oxidative burst and cytokine secretion (IL-1β, TGF-β).
• EV-associated CD39 and CD73 enzymes degrade extracellular ATP to adenosine, mediating anti-inflammatory effects on neutrophils via A2A receptors.
• EVs enhance neutrophil-macrophage conjugate formation and modulate macrophage inflammatory responses.

Conclusions:

• Plasma-derived EVs act as critical homeostatic regulators of inflammation.
• EVs exert distinct regulatory effects on macrophages and neutrophils through multiple mechanisms.
• EVs represent a promising target for immunomodulatory therapies.